Abstract:Cardiac fibrosis accompanies numerous cardiovascular diseases (CVD) such as hypertension and myocardial infarction and increases myocardial stiffness leading to contractile dysfunction. Recently, endothelial-to-mesenchymal transition (EndMT) has been shown to contribute to myocardial fibrosis. EndMT describes a process by which endothelial cells transform into mesenchymal cells such as fibroblasts and has been implicated in many fibrotic diseases. Angiotensin II (AngII) plays a key role in myocardial fibrosis and has been associated with the activation of fibroblasts to myofibroblasts and an increase in myocardial collagen deposition. Here, we assessed the role of AngII in capillary loss and EndMT in vivo and in vitro . C57BL/6J mice were infused with H 2 O (control) or 24μg/kg/hr AngII for 4 weeks. Mice infused with AngII developed significant cardiac fibrosis characterised by the deposition of collagen I (2.5-fold vs. control; p<0.05) and III (1.9-fold vs. control; p<0.05). Capillary density was assessed by CD31 immunohistochemistry and revealed significant vascular rarefaction (control 2161±111 vs . AngII 838±132 capillaries/mm 2 ; p<0.05). To investigate whether AngII can induce EndMT in vitro , human coronary artery endothelial cells were stimulated with 10ng/mL TGFβ 1 alone or in combination with 1μM AngII for 10 days. AngII significantly enhanced TGFβ 1 -induced gene expression of α-smooth muscle actin (TGFβ 1 1.8-fold; TGFβ 1 ±AngII 4.3-fold vs . control; p<0.05) and collagen I (TGFβ 1 9.2-fold; TGFβ 1 +AngII 30.2-fold vs . control; p<0.05). Concomitantly, AngII significantly increased α-smooth muscle actin protein expression (TGFβ 1 3.9-fold; TGFβ 1 +AngII 23.6-fold vs . control; p<0.05) and significantly decreased CD31 expression (TGFβ 1 0.9-fold; TGFβ 1 +AngII 0.7-fold vs . control; p<0.05), suggesting AngII acts in concert with TGFβ 1 to enhance conversion of endothelial cells to myofibroblasts. Further studies investigating the underlying mechanism, including the role of the Smad pathway, are ongoing. These results demonstrate that AngII induces vascular rarefaction in vivo and potentiates TGFβ 1 -induced EndMT in vitro. Understanding the molecular basis for these observations may help to identify new therapeutic options in CVD.

Membrane Raft Redox Signalling Contributes to Endothelial Dysfunction and Vascular Remodelling of Thoracic Aorta in Angiotensin II‐infused Rats

Membrane Rafts-Redox Signalling Pathway Contributes To Renal Fibrosis Via Modulation Of The Renal Tubular Epithelial-Mesenchymal Transition

Impaired Endothelial Relaxation and Enhanced Endothelial Contraction and Microvascular Adma in Angiotensin Ii Infused Rats: Effects of Tempol

Contribution of Acid Sphingomyelinase to Angiotensin II-induced Vascular Adventitial Remodeling Via Membrane Rafts/nox2 Signal Pathway

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

Ca2+-regulated Lysosome Fusion Mediates Angiotensin II-induced Lipid Raft Clustering in Mesenteric Endothelial Cells

Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro

Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload

Angiotensin Ii Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature - A Potential Link Between The Renin-Angiotensin System And Atherosclerosis

Impaired Endothelial Function and Microvascular Asymmetrical Dimethylarginine in Angiotensin Ii-Infused Rats Effects of Tempol

Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression in Rat Vasculature

Angiotensin II Infusion Alters Vascular Function in Mouse Resistance Vessels: Roles of O–·2 and Endothelium

Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II.

Mitochondrial KATP Channel-Mediated Autophagy Contributes to Angiotensin II-induced Vascular Dysfunction in Mice

Angiotensin II and Endothelin-1 Regulate MAP Kinases Through Different Redox-Dependent Mechanisms in Human Vascular Smooth Muscle Cells

Mitochondrial K ATP channel-mediated autophagy contributes to angiotensin II-induced vascular dysfunction in mice

MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling

Novel Mechanism of Angiotensin II-induced Cardiac Injury in Hypertensive Rats: the Critical Role of ASK1 and VEGF.

Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway

Possibly of Angiotesin II-induced Brain Microvascular Endothelial Cell Injury Through Oxidative Stress

Membrane Raft-Lysosome Redox Signalling Platforms in Coronary Endothelial Dysfunction Induced by Adipokine Visfatin.